Lymphoma

Top Story

Will CAR T cells become first-line therapy for hematologic malignancies?

Will CAR T cells become first-line therapy for hematologic malignancies?
HemOnc Today, March 25, 2019
Cover Story

New indications may accelerate ‘explosion’ in CAR T-cell therapy, but more education still needed

HemOnc Today, March 25, 2019
Years of research into chimeric antigen receptor T-cell therapy for cancer treatment is finally paying dividends. When Renier J. Brentjens, MD, PhD, director of…
Meeting News

Experts debate CAR T-cell therapy vs. transplant for relapsed diffuse large B-cell lymphoma

March 23, 2019
NEW YORK — Chimeric antigen receptor T-cell therapy confers better outcomes than autologous stem cell transplant to some patients with relapsed diffuse large…

CAR T-cell therapy changing the landscape of lymphoma treatment

March 23, 2019
NEW YORK — Chimeric antigen receptor T cell therapies could be the breakthrough hematologists have sought to effectively treat certain patients with lymphoma…
More Headlines »
CME

Updates in Hematologic Malignancies: What You Might Have Missed in San Diego

This activity is supported by an educational grant from Pharmacyclics LLC.

Therapeutic options continue to expand for patients with hematologic malignancies. The clinical evaluation of novel…
More »
Video

Baseball Hall of Famer Mike Schmidt promotes sun protection, skin cancer awareness

September 28, 2017
More »
Resource Centers

CME CNE

Improving Colorectal Cancer Screening and Prevention: Advances in Polyp Detection and Resection

This activity is supported by an educational grant from Aries Pharmaceuticals, Inc.

Colorectal cancer (CRC) is the third most common type of cancer worldwide and the second deadliest form of cancer in…
More »